相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights
Maria I. Carlo et al.
EUROPEAN UROLOGY (2019)
Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?
Megan Parilla et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management
Eamonn R. Maher
WORLD JOURNAL OF UROLOGY (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)
Christopher J. Ricketts et al.
CELL REPORTS (2018)
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
Maria I. Carlo et al.
JAMA ONCOLOGY (2018)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Sebastian Walpole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
Shengming Jin et al.
JOURNAL OF CANCER (2018)
Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays
Sabah Kadri et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Extent of renal vein invasion influences prognosis in patients with renal cell carcinoma
Mark W. Ball et al.
BJU INTERNATIONAL (2016)
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases
K. Rai et al.
CLINICAL GENETICS (2016)
Eosinophilic, Solid, and Cystic Renal Cell Carcinoma Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women
Kiril Trpkov et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response
Takayo Fukuda et al.
CURRENT CANCER DRUG TARGETS (2016)
Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma
Daniele Minardi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
Eric Talevich et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies
Francesco Piva et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Loss of PBRMI and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma
Thai H. Ho et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
Sean R. Williamson et al.
MODERN PATHOLOGY (2015)
Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity A Clinicopathologic Series of 36 Tumors From 27 Patients
Anthony J. Gill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Hereditary Leiomyomatosis and Reenal Cell Carcinoma Syndrome-associated Renal Cancer Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry
Ying-Bei Chen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Loss of BAP1 Protein Expression Is an Independent Marker of Poor Prognosis in Patients With Low-Risk Clear Cell Renal Cell Carcinoma
Richard W. Joseph et al.
CANCER (2014)
Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art
J. Michael Randall et al.
CANCER AND METASTASIS REVIEWS (2014)
BAP1 Immunohistochemistry Predicts Outcomes in a Multi-Institutional Cohort with Clear Cell Renal Cell Carcinoma
Payal Kapur et al.
JOURNAL OF UROLOGY (2014)
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis
Shan-Shan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Germline BAP1 Mutations Predispose to Renal Cell Carcinomas
Tatiana Popova et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Utilization of a TFE3 Break-apart FISH Assay in a Renal Tumor Consultation Service
Whitney M. Green et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation-associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone Expanding the Morphologic Spectrum
Qiu Rao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
James Brugarolas
CANCER JOURNAL (2013)
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
A. Ari Hakimi et al.
CLINICAL CANCER RESEARCH (2013)
A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
Megan N. Farley et al.
MOLECULAR CANCER RESEARCH (2013)
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
Payal Kapur et al.
LANCET ONCOLOGY (2013)
BAP1 expression in cutaneous melanoma: a pilot study
Rajmohan Murali et al.
PATHOLOGY (2013)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
Naoto Kuroda et al.
MEDICAL MOLECULAR MORPHOLOGY (2010)
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Kiran Gupta et al.
CANCER TREATMENT REVIEWS (2008)
Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay
P Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
分享论文
